Literature DB >> 670084

Globomycin, a new peptide antibiotic with spheroplast-forming activity. I. Taxonomy of producing organisms and fermentation.

M Inukai, R Enokita, A Torikata, M Nakahara, S Iwado, M Arai.   

Abstract

A new peptide antibiotic, globomycin, was found to be produced by four different strains of the actinomycetes. They were identified as Streptomyces halstedii No. 13912, Streptoverticillium cinnamoneum No. 15037, Streptomyces neohygroscopicus subsp. globomyceticus No. 15631 and Streptomyces hagronensis No. 17834, respectively. Fermentation of globomycin was conducted by conventional submerged culture for antibiotic production, in which 10 microgram/ml of globomycin was produced by cultivation of S. halstedii No. 13912 for 96 hours at 27 degrees C. Globomycin was named after its activity to form global-shape spheroplasts when Escherichia coli was incubated in the presence of this antibiotic.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 670084     DOI: 10.7164/antibiotics.31.410

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  8 in total

1.  Lethality of the covalent linkage between mislocalized major outer membrane lipoprotein and the peptidoglycan of Escherichia coli.

Authors:  T Yakushi; T Tajima; S Matsuyama; H Tokuda
Journal:  J Bacteriol       Date:  1997-05       Impact factor: 3.490

2.  Existence of the bound form of prolipoprotein in Escherichia coli B cells treated with globomycin.

Authors:  M Inukai; M Takeuchi; K Shimizu; M Arai
Journal:  J Bacteriol       Date:  1979-12       Impact factor: 3.490

3.  Mutational and biochemical analysis of cytochrome c', a nitric oxide-binding lipoprotein important for adaptation of Neisseria gonorrhoeae to oxygen-limited growth.

Authors:  Susan M Turner; James W B Moir; Lesley Griffiths; Timothy W Overton; Harry Smith; Jeff A Cole
Journal:  Biochem J       Date:  2005-06-01       Impact factor: 3.857

4.  Enteric YaiW is a surface-exposed outer membrane lipoprotein that affects sensitivity to an antimicrobial peptide.

Authors:  Markus F F Arnold; Paola Caro-Hernandez; Karen Tan; Giulia Runti; Silvia Wehmeier; Marco Scocchi; William T Doerrler; Graham C Walker; Gail P Ferguson
Journal:  J Bacteriol       Date:  2013-11-08       Impact factor: 3.490

5.  A novel cytochrome c peroxidase from Neisseria gonorrhoeae: a lipoprotein from a Gram-negative bacterium.

Authors:  Susan Turner; Eleanor Reid; Harry Smith; Jeffrey Cole
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

6.  Globomycin sensitivity of Escherichia coli and Salmonella typhimurium: effects of mutations affecting structures of murein lipoprotein.

Authors:  J S Lai; W M Philbrick; S Hayashi; M Inukai; M Arai; Y Hirota; H C Wu
Journal:  J Bacteriol       Date:  1981-01       Impact factor: 3.490

7.  Lipoprotein biosynthesis as a target for anti-Wolbachia treatment of filarial nematodes.

Authors:  Kelly L Johnston; Bo Wu; Ana Guimarães; Louise Ford; Barton E Slatko; Mark J Taylor
Journal:  Parasit Vectors       Date:  2010-10-14       Impact factor: 3.876

Review 8.  Mode of action of lipoprotein modification enzymes-Novel antibacterial targets.

Authors:  Simon Legood; Ivo G Boneca; Nienke Buddelmeijer
Journal:  Mol Microbiol       Date:  2020-10-12       Impact factor: 3.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.